Patents by Inventor Piere-Etienne Chabrier De Lassauniere

Piere-Etienne Chabrier De Lassauniere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
    Patent number: 9259458
    Abstract: The present invention relates to at least one botulinum neurotoxin for treatment or prevention of pain associated with diabetic neuropathy wherein said botulinum neurotoxin is prepared for local administration, wherein the local administration is not in the central nervous system (CNS), and wherein pain is treated at a site distant to the site of administration.
    Type: Grant
    Filed: February 7, 2014
    Date of Patent: February 16, 2016
    Assignee: IPSEN PHARMA S.A.S.
    Inventors: Christine Favre, Michel Auguet, Piere-Etienne Chabrier De Lassauniere
  • Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
    Patent number: 8784841
    Abstract: The present invention relates to at least one botulinum neurotoxin for treatment of prevention of pain associated with diabetic neuropathy wherein said botulinum neurotoxin is prepared for local administration, wherein the local administration is not in the central nervous system (CNS), and wherein pain is treated at a site distant to the site of administration.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: July 22, 2014
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Christine Favre, Michel Auguet, Piere-Etienne Chabrier De Lassauniere
  • Therapeutic Use of Botulinum Neurotoxin in the Treatment of pain associated with diabetic neuropathy
    Publication number: 20140154781
    Abstract: The present invention relates to at least one botulinum neurotoxin for treatment or prevention of pain associated with diabetic neuropathy wherein said botulinum neurotoxin is prepared for local administration, wherein the local administration is not in the central nervous system (CNS), and wherein pain is treated at a site distant to the site of administration.
    Type: Application
    Filed: February 7, 2014
    Publication date: June 5, 2014
    Applicant: IPSEN PHARMA S.A.S.
    Inventors: Christine FAVRE, Michel AUGUET, Piere-Etienne CHABRIER DE LASSAUNIERE
  • THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY
    Publication number: 20110038893
    Abstract: The present invention relates to at least one botulinum neurotoxin for treatment of prevention of pain associated with diabetic neuropathy wherein said botulinum neurotoxin is prepared for local administration, wherein the local administration is not in the central nervous system (CNS), and wherein pain is treated at a site distant to the site of administration.
    Type: Application
    Filed: April 27, 2009
    Publication date: February 17, 2011
    Applicant: IPSEN PHARMA S.A.S.
    Inventors: Christine Favre, Michel Auguet, Piere-Etienne Chabrier De Lassauniere
  • Use of botulinum toxin for the preparation of a medicament for the treatment of lithiasis of salivary gland, gall bladder, kidney, or pancreas
    Patent number: 7838009
    Abstract: The invention relates to the use of a pre-synaptic neuromuscular blocking substance for preparing a medicament intended to treat a gland, organ or duct obstructed by a naturally formed stone. This method can be applied notably for salivary gland, gall bladder, kidney or pancreas stones.
    Type: Grant
    Filed: July 6, 2005
    Date of Patent: November 23, 2010
    Assignees: Ipsen Pharma S.A.S., Ipsen Biopharm Limited
    Inventors: Pierre Bernard D'Arbigny, Piere-Etienne Chabrier De Lassauniere, Alan Barcock